These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 23419133)

  • 1. Low serum fetuin A levels and incident stroke in patients with maintenance haemodialysis.
    Chen HY; Chiu YL; Hsu SP; Pai MF; Yang JY; Peng YS
    Eur J Clin Invest; 2013 Apr; 43(4):387-96. PubMed ID: 23419133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of low serum fetuin A levels with poor arteriovenous access patency in patients undergoing maintenance hemodialysis.
    Chen HY; Chiu YL; Chuang YF; Hsu SP; Pai MF; Lai CF; Yang JY; Peng YS; Tsai TJ; Wu KD
    Am J Kidney Dis; 2010 Oct; 56(4):720-7. PubMed ID: 20801568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between Fetuin A, Vascular Calcification and Fracture Risk in Dialysis Patients.
    Chen HY; Chiu YL; Hsu SP; Pai MF; Yang JY; Peng YS
    PLoS One; 2016; 11(7):e0158789. PubMed ID: 27398932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low serum fetuin-A concentration predicts poor outcome only in the presence of inflammation in prevalent haemodialysis patients.
    Metry G; Stenvinkel P; Qureshi AR; Carrero JJ; Yilmaz MI; Bárány P; Snaedal S; Heimbürger O; Lindholm B; Suliman ME
    Eur J Clin Invest; 2008 Nov; 38(11):804-11. PubMed ID: 19021697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fetuin A/nutritional status predicts cardiovascular outcomes and survival in hemodialysis patients.
    Chen HY; Chiu YL; Hsu SP; Pai MF; Yang JY; Peng YS
    Am J Nephrol; 2014; 40(3):233-41. PubMed ID: 25322785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum fetuin a in hemodialysis: a link between derangement of calcium-phosphorus homeostasis and progression of atherosclerosis?
    Pertosa G; Simone S; Ciccone M; Porreca S; Zaza G; Dalfino G; Memoli B; Procino A; Bonomini M; Sirolli V; Castellano G; Gesualdo L; Ktena M; Schena FP; Grandaliano G
    Am J Kidney Dis; 2009 Mar; 53(3):467-74. PubMed ID: 19167798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers of vascular calcification and mortality in patients with ESRD.
    Scialla JJ; Kao WH; Crainiceanu C; Sozio SM; Oberai PC; Shafi T; Coresh J; Powe NR; Plantinga LC; Jaar BG; Parekh RS
    Clin J Am Soc Nephrol; 2014 Apr; 9(4):745-55. PubMed ID: 24458076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of Serum Calciprotein Particle Size and Transformation Time With Arterial Calcification, Arterial Stiffness, and Mortality in Incident Hemodialysis Patients.
    Chen W; Fitzpatrick J; Monroy-Trujillo JM; Sozio SM; Jaar BG; Estrella MM; Serrano J; Anokhina V; Miller BL; Melamed ML; Bushinsky DA; Parekh RS
    Am J Kidney Dis; 2021 Mar; 77(3):346-354. PubMed ID: 32800846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain natriuretic peptide between traditional and nontraditional risk factors in hemodialysis patients: analysis of cardiovascular mortality in a two-year follow-up.
    Selim G; Stojceva-Taneva O; Spasovski G; Georgievska-Ismail L; Zafirovska-Ivanovska B; Gelev S; Dzekova P; Trajcevska L; Trojacanec-Piponska S; Sikole A
    Nephron Clin Pract; 2011; 119(2):c162-70. PubMed ID: 21757955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemodialysis and the risk of stroke: A population-based cohort study in Taiwan, a country of high incidence of end-stage renal disease.
    Kuo CC; Lee CT; Ho SC; Kuo HW; Wu TN; Yang CY
    Nephrology (Carlton); 2012 Mar; 17(3):243-8. PubMed ID: 22171843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fetuin-A, glycemic status, and risk of cardiovascular disease: The Multi-Ethnic Study of Atherosclerosis.
    Aroner SA; St-Jules DE; Mukamal KJ; Katz R; Shlipak MG; Criqui MH; Kestenbaum B; Siscovick DS; de Boer IH; Jenny NS; Budoff MJ; Ix JH; Jensen MK
    Atherosclerosis; 2016 May; 248():224-9. PubMed ID: 27038419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of dialysis modality and infectious mortality in incident dialysis patients in Australia and New Zealand.
    Johnson DW; Dent H; Hawley CM; McDonald SP; Rosman JB; Brown FG; Bannister KM; Wiggins KJ
    Am J Kidney Dis; 2009 Feb; 53(2):290-7. PubMed ID: 18805609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fetuin-A pretransplant serum levels, kidney allograft function and rejection episodes: a 3-year posttransplantation follow-up.
    Roos M; Heinemann FM; Lindemann M; Horn PA; Lutz J; Stock K; Thürmel K; Baumann M; Witzke O; Heemann U
    Kidney Blood Press Res; 2011; 34(5):328-33. PubMed ID: 21613794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of serum fetuin A with truncal obesity and dyslipidemia in non-diabetic hemodialysis patients.
    Chen HY; Chiu YL; Hsu SP; Pai MF; Lai CF; Peng YS; Kao TW; Hung KY; Tsai TJ; Wu KD
    Eur J Endocrinol; 2009 May; 160(5):777-83. PubMed ID: 19228823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients.
    Wang AY; Woo J; Lam CW; Wang M; Chan IH; Gao P; Lui SF; Li PK; Sanderson JE
    Nephrol Dial Transplant; 2005 Aug; 20(8):1676-85. PubMed ID: 15899935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there any survival advantage of obesity in Southern European haemodialysis patients?
    Chazot C; Gassia JP; Di Benedetto A; Cesare S; Ponce P; Marcelli D
    Nephrol Dial Transplant; 2009 Sep; 24(9):2871-6. PubMed ID: 19369686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study on the relationship of serum fetuin-A concentration with aortic stiffness in patients on dialysis.
    Hermans MM; Brandenburg V; Ketteler M; Kooman JP; van der Sande FM; Gladziwa U; Rensma PL; Bartelet K; Konings CJ; Hoeks AP; Floege J; Leunissen KM
    Nephrol Dial Transplant; 2006 May; 21(5):1293-9. PubMed ID: 16396973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum Fetuin-A and Pentraxin3 in hemodialysis and renal transplant patients.
    Argani H; Ghorbanihaghjo A; Panahi G; Rashtchizadeh N; Safa J; Meimand SM
    Clin Biochem; 2012 Jul; 45(10-11):775-9. PubMed ID: 22546644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylated fetuin-A-containing calciprotein particles are associated with aortic stiffness and a procalcific milieu in patients with pre-dialysis CKD.
    Smith ER; Ford ML; Tomlinson LA; Rajkumar C; McMahon LP; Holt SG
    Nephrol Dial Transplant; 2012 May; 27(5):1957-66. PubMed ID: 22105144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of serum FGF-23, MGP and fetuin-A on calcium-phosphate metabolism in maintenance hemodialysis patients.
    Xiao DM; Wu Q; Fan WF; Ye XW; Niu JY; Gu Y
    Hemodial Int; 2013 Oct; 17(4):483-92. PubMed ID: 23490272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.